WuXi PharmaTech reported that its Q4 revenues were up 64% over the year earlier, coming in at $37.1 million. Net income more than tripled, rising 205.7% to $12.1 million. The numbers mean that earnings per ADS were 17 cents, fully diluted. WuXi also forecast much higher revenues of $280 million to $300 million in 2008, though this includes revenue from the AppTec acquisition.  More details...

Stock Symbol: (NYSE: WX)